In over 22 years, I have exposed the hidden agenda of the FDA in not being the watchdogs of the American people but rather exhibiting questionable behavior.

Have you ever attended FDA meetings where drugs with very adverse effects have been approved?
Have you ever sat in a huge FDA auditorium with only approximately six people in attendance while officials at the FDA take testimony from pharmaceutical representative experts?

Have you ever listened to an “expert” from a pharmaceutical company speak at an FDA meeting who had the DEA investigate him for over 30 deaths at his medical facility?

Have you ever had weekly dialogue with an FDA official for over two years regarding criminal marketing of dangerous drugs?

If you answer “no” to the above questions, I can answer “yes” to every question.

In 2021, I had an article published regarding then Commissioner Margaret Hamburg, MD and her hedge fund husband, Renaissance Technologies Co-Chief Executive Officer and Co-President and Director Peter Fitzhugh Brown.

In December 2015, Renaissance Technologies, LLC, a leading hedge fund institution, purchased 61,913 shares of Titan Pharmaceuticals. Dr. Hamburg retired as Commissioner of the FDA in 2015.

Was there any investigation into a conflict of interest with Margaret Hamburg, Titan Pharmaceuticals, Peter Fitzhugh Brown and Renaissance Technologies?

The above is only the tip of the iceberg.  The iceberg underwater is called Janet Woodcock, MD, Bob Rappaport, MD, Doug Throckmorton, MD, Sharon Hertz, MD and Ellen Fields, MD with others manning lifeboats.

Here are links to some of my previously, published articles on the FDA and its questionable dealings in partnership with the pharmaceutical industry.

“Is FDA’s Margaret Hamburg, MD Contributing to the U.S. Heroin and Opioid Epidemic by Living in an Ivory Tower?”) salem-news.com/articles/april132014/hamburg-addiction-ms.php